Showing 1,261 - 1,280 results of 101,543 for search '(( 50 ((nn decrease) OR (mean decrease)) ) OR ( 5 ((nm decrease) OR (a decrease)) ))', query time: 1.52s Refine Results
  1. 1261
  2. 1262
  3. 1263
  4. 1264
  5. 1265

    Table1_Open Screw Placement in a 1.5 mm LCP Over a Fracture Gap Decreases Fatigue Life.docx by Sarah G. J. Alwen (5263049)

    Published 2018
    “…Objective<p>To investigate the influence of plate and screw hole position on the stability of simulated radial fractures stabilized with a 1.5 mm condylar locking compression plate (LCP).…”
  6. 1266
  7. 1267
  8. 1268
  9. 1269
  10. 1270

    Proliferative keratinocytes and BrdU-positive label retaining cells are decreased in <i>Med1<sup>epi−/−</sup></i> mice. by Fumihito Noguchi (615295)

    Published 2014
    “…Scale bars = 50 µm. B: Quantification of proliferating cells on days 1, 3 and 5 after injury. …”
  11. 1271
  12. 1272
  13. 1273
  14. 1274
  15. 1275

    Juvenile demyelination leads to a decrease in axonal complexity of PFC PV interneurons. by Sara Hijazi (21656615)

    Published 2025
    “…</b> Quantification of the overall myelin intensity in PFC of both groups shows a clear loss of myelin in the juvenile demyelination group (<i>t test; n = 6/5 mice per group, ***p < 0.001</i>). …”
  16. 1276
  17. 1277
  18. 1278
  19. 1279

    Structure-Based Design of a Chemical Probe Set for the 5‑HT<sub>5A</sub> Serotonin Receptor by Anat Levit Kaplan (12126567)

    Published 2022
    “…Docking over 6 million molecules against a 5-HT<sub>5A</sub>R homology model identified 5 mid-μM ligands, one of which was optimized to <b>UCSF678</b>, a 42 nM arrestin-biased partial agonist at the 5-HT<sub>5A</sub>R with a more restricted off-target profile and decreased assay liabilities versus SB-699551. …”
  20. 1280

    Structure-Based Design of a Chemical Probe Set for the 5‑HT<sub>5A</sub> Serotonin Receptor by Anat Levit Kaplan (12126567)

    Published 2022
    “…Docking over 6 million molecules against a 5-HT<sub>5A</sub>R homology model identified 5 mid-μM ligands, one of which was optimized to <b>UCSF678</b>, a 42 nM arrestin-biased partial agonist at the 5-HT<sub>5A</sub>R with a more restricted off-target profile and decreased assay liabilities versus SB-699551. …”